EP Patent

EP0993827A4 — AEROSOLS

Assigned to Taisho Pharmaceutical Co Ltd · Expires 2006-07-05 · 20y expired

What this patent protects

Aerosols for cooling the skin, which are composed of a stock solution containing lower (C1-3) alcohols and liner C10-22 monocarboxylic acids and a liquefied gas and which, after spraying, solidify in a sherbet-like mode at the application sites. The aerosols can contain drugs whi…

USPTO Abstract

Aerosols for cooling the skin, which are composed of a stock solution containing lower (C1-3) alcohols and liner C10-22 monocarboxylic acids and a liquefied gas and which, after spraying, solidify in a sherbet-like mode at the application sites. The aerosols can contain drugs which have been difficult to add to conventional ones, give a good feel in using and achieve a sustained cooling effect. These characteristics make them efficacious in quickly relieving pains due to bruise, sprain, muscular fatigue, etc. and itching due to athlete's foot, insect bite, etc.

Drugs covered by this patent

Patent Metadata

Patent number
EP0993827A4
Jurisdiction
EP
Classification
Expires
2006-07-05
Drug substance claim
No
Drug product claim
No
Assignee
Taisho Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.